Solventum Corporation
Market Cap
$11.69B
P/E Ratio
7.59
EPS
$8.88
Dividend Yield
0.00%
52-Week Range
$62.38 — $88.20
Volume
1.51M
Avg Volume
1.28M
Beta
0.77
Get alerted when SOLV hits your target price.
Free — enter your email to get started
P/E (TTM)
7.59
Forward P/E
10.62
PEG Ratio
0.03
P/S (TTM)
1.45
P/B (TTM)
2.41
P/FCF
-605.90
EV/EBITDA
9.41x
EV/Sales
—
ROE (TTM)
0.37%
ROA (TTM)
0.11%
ROIC
0.01%
Gross Margin
0.53%
Operating Margin
0.26%
Net Margin
0.60%
Debt/Equity
1.00
Current Ratio
1.23
EPS Growth (YoY)
+9.32%
Revenue Growth (YoY)
+0.00%
EPS Growth (3Y)
+0.53%
EPS Growth (5Y)
+0.36%
Sales Growth (3Y)
+0.01%
Sales Growth (5Y)
+0.03%
EPS Est (This Year)
$6.34
EPS Est (Next Year)
$6.90
Dividend Yield
—
Annual Dividend
—
Payout Ratio
0.00%
Frequency
—
Ex-Dividend Date
—
Cash/Share
$5.04
Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $95.80(42.2% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
173.45M
Float
147.36M
Free Float %
84.96%
Sector
Healthcare
Industry
Medical - Care Facilities
Country
US
Exchange
NYSE
IPO Date
2024-04-01
Employees
22000
CEO
Bryan C. Hanson
Index Membership
S&P 500
Website
https://www.solventum.com
Solventum Corporation (SOLV) is a healthcare company in the medical - care facilities industry listed on the NYSE. With a market capitalization of $11.69B, a P/E ratio of 7.59, SOLV is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare SOLV against other stocks using dozens of fundamental and technical filters.
Solventum Corporation (SOLV) has a trailing twelve-month (TTM) P/E ratio of 7.59. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Solventum Corporation (SOLV) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Solventum Corporation (SOLV) has a market capitalization of $11.69 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on Solventum Corporation (SOLV) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $95.80 implies 42.2% upside from the current price.